Pharming Group NV: Human protein replacement therapies, initially in rare/ultra-rare diseases, plus new small molecule program for APDS. RUCONEST (rhC1INH), the only recombinant enzyme replacement therapy marketed for acute Hereditary Angioedema (HAE) attacks and being developed for large unmet indications. Profitable and cash flow positive – revenue from product sales €134M (2018) and €123M (1st 9 months 2019). Growth (9 mo. YOY) in revenues (+26%), operating profit (+38%) and net profit (+73%). Development pipeline includes RUCONEST in new versions (LCM), new license from Novartis of late stage drug Leniolisib for APDS (ultra-rare immunodeficiency condition), rhC1INH for new larger indications including pre-eclampsia (data exp. Q3 2020) and AKI, recombinant alpha-Glucosidase for Pompe disease.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Marketed
Disease Space
Anti-inflammatory, Autoimmune, Rare Disease
Finance
Profitable, Revenues
Industry
Biotechnology
Listing
Europe, Public
Market Cap
500MM - 1B
Therapeutic Modalities
Recombinant DNA
Website:
Address:
Darwinweg 24
Leiden, 2333 CR
Netherlands

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Pharming Group NV

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Goldman Sachs Asset Management LP 2.20 13,674,620 18.20 Stakes 2020-04-03
Schroder Investment Management Ltd. 0.79 4,917,717 6.54 Funds 2020-05-31
DWS Investments (UK) Ltd. 0.63 3,887,739 5.17 Stakes 2020-04-21
Norges Bank Investment Management 0.55 3,427,053 4.56 Funds 2019-12-31
Argenta Banque d'Epargne SA 0.50 3,096,235 4.12 Funds 2020-05-27
Schroder Investment Management North America, Inc. 0.48 3,011,586 4.01 Funds 2020-05-31
RAM Active Investments SA 0.45 2,824,937 3.76 Funds 2019-12-31
Principal Global Investors LLC 0.31 1,918,093 2.55 Funds 2020-03-31
First Private Investment Management KAG mbH 0.29 1,818,313 2.42 Funds 2020-02-28
Bessemer Investment Management LLC 0.29 1,792,588 2.39 Funds 2020-04-30
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.